https://www.selleckchem.com/products/raphin1.html
85, = 0.02] and 19% in the obese category (OR 3.95, = 0.04). Statin use was associated with severe or severe, complicated CDI when controlling for age and BMI (OR 5.66, = 0.01). There was no association between statin use and IBD exacerbations following CDI. Opioid and antidepressant use were not associated with disease severity or frequency of IBD exacerbations following CDI. An overweight BMI and statin use were associated with severe or severe, complicated CDI in IBD patients. Further studies are needed to better understand how th
Мне нравится
Комментарий
Перепост
